It is shown that identification tests of different dimensions or dimensionless should not be evaluated (for their efficiency to identify molecules from their mass spectrum) by comparing the tests for a molecule itself (repeated measurements) with other molecules. This kind of tests must have similar dimensions (units). Another possibility is the comparison of tests on the basis of success of correct prediction for "unknown" molecules from a library of standards.
No takes yet. Share an insight, caveat, or question.
Zeev B. Alfassi (2003) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: